Welcome to our dedicated page for Cooper news (Ticker: COO), a resource for investors and traders seeking the latest updates and insights on Cooper stock.
The Cooper Companies, Inc. reports developments for a global medical device business organized around CooperVision and CooperSurgical. CooperVision news centers on soft contact lenses, specialty lens designs, myopia management products such as MiSight® 1 day, MyDay® contact lenses, practitioner support, and sustainability initiatives tied to lens materials, packaging, manufacturing, and plastic footprint programs.
CooperCompanies news also covers quarterly financial results, conference participation, board appointments, and governance matters. CooperSurgical provides fertility and women’s healthcare products, while companywide updates describe operating performance, capital priorities, and corporate developments across its medical device portfolio.
CooperCompanies (Nasdaq: COO), a global leader in medical devices, announced its participation in the Jefferies Global Healthcare Conference on June 6, 2024. Brian Andrews, the Executive Vice President, Chief Financial Officer & Treasurer, will represent the company in a session at 1:30 PM ET. The presentation will be accessible via a webcast on the CooperCompanies' investor relations website.
CooperCompanies (Nasdaq: COO), a global medical device firm, is set to participate in the William Blair Growth Stock Conference on June 5, 2024. Dan McBride, Executive Vice President & Chief Operating Officer, will represent the company in a session at 11:00 AM ET. Interested parties can view the webcast via the CooperCompanies' investor website.
The Canadian Association of Optometrists has launched a digital campaign called 'GetEyeWise' during Vision Health Month to raise awareness about eye health and encourage regular eye exams. The campaign aims to educate Canadians about the importance of eye care, especially early detection of eye-threatening conditions. With the support of various provincial associations of optometrists and industry sponsors, the initiative highlights the urgent need for public education on eye health and vision care.
CooperCompanies will release its second quarter 2024 financial results on May 30, 2024, at 4:15 PM ET. A conference call to discuss the results and corporate developments will follow at 5:00 PM ET. Investors can access the call via dial-in number 800-715-9871 and conference ID 1712676. An audio webcast and replay will be available at http://investor.coopercos.com.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.